FY2025 · ended Dec 31, 2025 · Revenue $1.91M, +3701.4% YoY · Filed Mar 31, 2026
Longevity Health Holdings, Inc. (XAGE) files with the SEC under industry code 2840, Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 million and a net loss of $6.9 million. Free cash flow was -$3.3 million. As of Jun 30, 2026 it held $35,471 in cash and investments and $260,647 in total debt.
Revenue (TTM)
$1.69M
+60.3% vs year-ago TTM
Net income (TTM)
$-6.83M
+5.0% vs year-ago TTM
Operating cash flow (TTM)
$-2.45M
+25.1% vs year-ago TTM
Free cash flow
$-3.34M
+60.1% vs prior year
EPS
$-4.83
+66.8% vs prior year
Dividend per share
None
Shares outstanding
2.48M
-91.8% vs prior year
Net cash
$-225,176
as of Jun 30, 2026
Operating margin
-343.6%
FY 2026
Company profile
- Industry
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (SIC 2840)
- Listed as
- XAGE (OTC), XAGEW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Pittsburgh, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1842939
- Former names
- Carmell Corp (until Feb 13, 2025); ALPHA HEALTHCARE ACQUISITION CORP III (until Jul 20, 2023)
Other Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies
- PROCTER & GAMBLE Co PG
- Unilever PLC UL
- Ecolab Inc. ECL
- Church & Dwight Co Inc /DE/ CHD
- Stepan Co SCL
- Meiwu Technology Co Ltd WNW
- Park Ha Biological Technology Co., Ltd. BYAH
- Orion Bliss Corp. ORIB
All 9 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.9M | $50,318 | — | — | — |
| Operating income | -$7.1M | -$5.0M | -$5.9M | -$5.5M | -$467,431 |
| Net income | -$6.9M | -$10.4M | -$15.4M | -$9.1M | -$329,382 |
| Diluted EPS | -$4.83 | -$14.56 | -$1.46 | — | — |
| Operating cash flow | -$3.3M | -$3.9M | -$8.3M | -$3.4M | -$451,167 |
| Free cash flow | -$3.3M | — | -$8.4M | — | — |
| Total assets | $2.4M | $1.5M | $63.9M | $1.7M | $155.4M |
| Total liabilities | $8.2M | $6.2M | $39.2M | $8.1M | $5.7M |
| Stockholders' equity | -$5.9M | -$4.7M | $24.7M | -$37.8M | -$29.6M |
| Cash and investments | $706,740 | — | $2.9M | — | $774,192 |
| Total debt | $309,938 | $397,835 | $847,851 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 4, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change, Other events
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2026 | Jun 1, 2026 |
All 338 Longevity Health Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.